STATE STREET CORP - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$233,855
-23.9%
167,0390.0%0.00%
Q2 2023$307,352
-31.3%
167,039
-9.3%
0.00%
Q1 2023$447,458
-15.0%
184,139
-50.0%
0.00%
Q4 2022$526,638
+27.2%
368,278
+98.4%
0.00%
Q3 2022$414,000
+7.8%
185,6390.0%0.00%
Q2 2022$384,000
-33.2%
185,639
-6.3%
0.00%
Q1 2022$575,000
-8.3%
198,133
+1.4%
0.00%
Q4 2021$627,000
-9.4%
195,3540.0%0.00%
Q3 2021$692,000
+11.8%
195,3540.0%0.00%
Q2 2021$619,000
-77.5%
195,354
-75.5%
0.00%
Q1 2021$2,746,000
+28.6%
798,318
-5.8%
0.00%
Q4 2020$2,136,000
+25.1%
847,546
+4.7%
0.00%
Q3 2020$1,708,000
-5.4%
809,383
+0.4%
0.00%
Q2 2020$1,806,000
-5.9%
806,072
+6.3%
0.00%
Q1 2020$1,919,000
-8.4%
758,632
-4.7%
0.00%
Q4 2019$2,094,000
-25.4%
796,152
+2.1%
0.00%
Q3 2019$2,806,000
+7.8%
779,419
+0.9%
0.00%
Q2 2019$2,602,000
+28.4%
772,093
+4.0%
0.00%
Q1 2019$2,027,000
-0.1%
742,444
+1.7%
0.00%
Q4 2018$2,030,000
-35.2%
730,075
-4.0%
0.00%
Q3 2018$3,135,000
-18.3%
760,740
+3.0%
0.00%
Q2 2018$3,835,000
-2.7%
738,702
+2.7%
0.00%
Q1 2018$3,940,000
-32.9%
719,343
-0.1%
0.00%
Q4 2017$5,870,000
-17.5%
720,137
+6.0%
0.00%
-100.0%
Q3 2017$7,113,000
-3.5%
679,314
+1.8%
0.00%0.0%
Q2 2017$7,373,000
+51.0%
667,535
+14.4%
0.00%
Q1 2017$4,884,000
+24.2%
583,492
+2.9%
0.00%
Q4 2016$3,931,000
+46.0%
567,070
+7.3%
0.00%
Q3 2016$2,693,000
-8.7%
528,398
+6.9%
0.00%
Q2 2016$2,949,000
+2878.8%
494,216
+2158.8%
0.00%
Q1 2016$99,0000.0%21,8800.0%0.00%
Q4 2015$99,000
+47.8%
21,880
+2.8%
0.00%
Q3 2015$67,000
+4.7%
21,2800.0%0.00%
Q2 2015$64,000
-94.9%
21,280
-95.0%
0.00%
Q1 2015$1,247,000
-20.2%
422,280
+20.0%
0.00%
Q4 2014$1,563,000
-10.6%
351,809
+3.5%
0.00%
Q3 2014$1,749,000
+2.0%
339,772
+4.0%
0.00%
Q2 2014$1,715,000
+1668.0%
326,854
+1286.1%
0.00%
Q1 2014$97,000
-59.6%
23,580
-72.8%
0.00%
Q4 2013$240,000
+300.0%
86,834
+268.3%
0.00%
Q3 2013$60,000
+22.4%
23,580
-0.1%
0.00%
Q2 2013$49,00023,5940.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2015
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders